menu
    • menu

    Company profile for Lakewood-Amedex

    NEW Drugs in Dev: 3
    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    Boai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    Nanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

    Virtual Booth

    Contact Supplier

    Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Lakewood-Amedex is a privately held, clinical stage pharmaceutical company developing a broad portfolio of first-in-class antimicrobial and antifungal therapeutics called bisphosphocins. The rapid bactericidal action of this novel class of antimicrobials has been demonstrated against more than 70 different bacterial strains so far, including many antibiotic-resistant and biofilm forming bacteria. In the growing crisis of multi...
    Lakewood-Amedex is a privately held, clinical stage pharmaceutical company developing a broad portfolio of first-in-class antimicrobial and antifungal therapeutics called bisphosphocins. The rapid bactericidal action of this novel class of antimicrobials has been demonstrated against more than 70 different bacterial strains so far, including many antibiotic-resistant and biofilm forming bacteria. In the growing crisis of multidrug-resistant infections, Lakewood’s clinical development pipeline is focused on addressing the most life-threatening disease indications.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Lakewood-AmedexUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    3030 University Pkwy, Sarasota, FL 34243
    Telephone
    Telephone
    (941) 225-2515
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://lakewoodamedex.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/lakewood-amedex-inc./
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Lakewood-Amedex Report Positive Nu-3 Data in Diabetic Foot Ulcers
    Lakewood-Amedex Report Positive Nu-3 Data in Diabetic Foot Ulcers

    18 May 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/lakewood-amedex-biotherapeutics-announces-positive-data-for-the-advancement-of-lead-candidate-nu-3-in-infected-diabetic-foot-ulcers-302773810.html

    PR NEWSWIRE
    18 May 2026
    Share Share
    Lakewood-Amedex Bio Partners With PERI For Nu-3 Phase 2 Trial
    Lakewood-Amedex Bio Partners With PERI For Nu-3 Phase 2 Trial

    12 May 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/lakewood-amedex-biotherapeutics-announces-agreement-with-peri-to-serve-as-cro-for-phase-2-clinical-trial-of-nu-3-302768839.html

    PR NEWSWIRE
    12 May 2026
    Share Share
    Lakewood-Amedex Announces Positive Diabetic Foot Ulcer Data
    Lakewood-Amedex Announces Positive Diabetic Foot Ulcer Data

    01 May 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/lakewood-amedex-biotherapeutics-announces-positive-antimicrobial-resistance-data-for-lead-candidate-targeting-infected-diabetic-foot-ulcers-302759775.html

    PR NEWSWIRE
    01 May 2026
    Share Share
    Lakewood-Amedex Bio Directly Lists LABT Shares on Nasdaq
    Lakewood-Amedex Bio Directly Lists LABT Shares on Nasdaq

    23 Apr 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/lakewood-amedex-biotherapeutics-announces-direct-listing-on-nasdaq-shares-trading-under-the-symbol-labt-302751953.html

    PR NEWSWIRE
    23 Apr 2026
    Share Share
    Lakewood-Amedex to Participate in Panel Discussion at BioFlorida
    Lakewood-Amedex to Participate in Panel Discussion at BioFlorida

    03 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/lakewood-amedex-biotherapeutics-to-participate-in-panel-discussion-at-biofloridas-florida-innovation-conference-302602687.html

    PR NEWSWIRE
    03 Nov 2025
    Share Share
    Lakewood-Amedex Publishes Data on Bisphosphocin’s Potent Activity
    Lakewood-Amedex Publishes Data on Bisphosphocin’s Potent Activity

    22 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/lakewood-amedex-biotherapeutics-announces-peer-reviewed-publication-demonstrating-potent-antimicrobial-activity-of-bisphosphocin-class-against-resistant-pathogens-302590806.html

    PR NEWSWIRE
    22 Oct 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search